Open access · OA
via Europe PMC
Cardiovascular health and longevity: where are we?
Seri A, Yue B, Khawaja M, Tang WHW, Birnbaum Y, Lavie CJ, Virani SS, Strauss M, Krittanawong C.
Frontiers in cardiovascular medicine · 2026
Telomere attrition
Epigenetic alterations
Dysbiosis
Mitochondrial dysfunction
Chronic inflammation
Exercise
Human
Review
Abstract
Cardiovascular health is a key factor in human longevity, affecting not just lifespan but also the quality of aging. We synthesize evidence across four risk factor domains: genetic and epigenetic factors (APOE, FOXO3, telomere(definition) biology, epigenetic clocks); metabolic and vascular factors (hyperglycemia, dyslipidemia, obesity, arterial stiffness); lifestyle determinants (diet, physical activity, smoking, sleep, gut microbiome); and environmental exposure (air and noise pollution, climate stressors, ionizing radiation). These factors influence various biological processes such as oxidative stress, chronic low grade inflammation (inflammaging(definition)), mitochondrial dysfunction(definition), metabolic disturbances, and changes in telomere length and epigenetics that collectively damage the endothelium, stiffen arteries, promote atherosclerosis, and contribute to overall cardiovascular decline with age. Understanding these processes helps explain why cardiovascular aging is such a strong predictor of mortality. We further summarize the principal intervention strategies with evidence for improving cardiovascular health and longevity, such as adherence to the American Heart Association's Life's Essential 8 construct, heart-healthy dietary patterns(Mediterranean, DASH), smoking cessation, sleep optimization, and reduction of environmental exposures. This narrative review distinguishes evidence derived from model organisms, human observational cohorts, and human interventional/genetic studies, since these evidence tiers differ substantially in their support for lifespan or longevity extending claims specifically, as opposed to cardiovascular risk reduction more broadly.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fcvm.2026.1921582
- Canonical
- link ↗
- Fetched
- 2026-11-10 MST
Cite this
APA
A, S., B, Y., M, K., WHW, T., Y, B., CJ, L., SS, V., M, S., & C., K. (2026). Cardiovascular health and longevity: where are we?. <em>Frontiers in cardiovascular medicine</em>. https://doi.org/10.3389/fcvm.2026.1921582
Vancouver
A S, B Y, M K, WHW T, Y B, CJ L, et al. Cardiovascular health and longevity: where are we?. Frontiers in cardiovascular medicine. 2026. doi:10.3389/fcvm.2026.1921582.
BibTeX
@article{seri2026Cardio,
title = {Cardiovascular health and longevity: where are we?},
author = {Seri A and Yue B and Khawaja M and Tang WHW and Birnbaum Y and Lavie CJ and Virani SS and Strauss M and Krittanawong C.},
journal = {Frontiers in cardiovascular medicine},
year = {2026},
doi = {10.3389/fcvm.2026.1921582},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Cardiovascular Medicine 2026
Open access · CC-BY
Cardiovascular health and longevity: where are we?
Chinese University of Hong Kong 2023
Open access · US-GOV
Hong Kong Cohort of Abnormal Sleep in Ageing Population (HK-ASAP): an Observational Study on Brain Health and Sleep Quality in Community-dwelling Older Adults
Scientific Reports 2017
Open access · CC-BY
Sleep disorder, an independent risk associated with arterial stiffness in menopause
Biogerontology 2026
Open access · CC-BY
Maternal biological ageing and telomere attrition across parity, pregnancy, and the postpartum period
Biogerontology 2026
Open access · OA
Maternal biological ageing and telomere attrition across parity, pregnancy, and the postpartum period.
Journal of Inflammation 2014
Open access · CC-BY